Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 04.10.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.10.24Grayscale Investments Announces Rebalancing of Multi-Asset Funds for Third Quarter 202420STAMFORD, Conn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Grayscale Investments®, an asset management firm with expertise in crypto investing, offering more than 20 crypto investment products, and manager...
► Artikel lesen
04.10.24Greenbrook TMS Inc.: Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings59MALVERN, Pa. and TORONTO, Oct. 4, 2024 /PRNewswire/ - Neuronetics, Inc. (NASDAQ: STIM) ("Neuronetics") and Greenbrook TMS Inc. (OTCMKTS: GBNHF) ("Greenbrook") today announced that the Ontario Superior...
► Artikel lesen
04.10.24ARHT Media Inc. Announces Filing for Bankruptcy80TORONTO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- ARHT Media Inc. (TSX-V:ART), (OTCQB:ARHTF) (the "Company" or "ARHT") has announced that it has filed for bankruptcy under the Bankruptcy and Insolvency Act...
► Artikel lesen
04.10.24Sigyn Therapeutics, Inc. - 8-K, Current Report-
04.10.24Avricore Health Inc. - 6-K, Report of foreign issuer2
04.10.24Moolec Science SA - 6-K, Report of foreign issuer-
04.10.24Maximum Entertainment AB: Christina Seelye and Thierry Bonnefoi have filed a request for arbitration against Maximum Entertainment92Stockholm, Sweden (October 4, 2024) - Maximum Entertainment AB (Nasdaq: MAXENT B) today announced that Christina Seelye and Thierry Bonnefoi have filed a request for arbitration with the Arbitration...
► Artikel lesen
04.10.24G7-Wettbewerbsgipfel in Rom: Politik und Wettbewerbsbehörden verabschieden Erklärung zu Künstlicher Intelligenz118Zum Ende des zweitägigen G7-Wettbewerbsgipfels in Rom haben Vertreterinnen und Vertreter der G7-Mitgliedsstaaten (Deutschland, Frankreich, Großbritannien, Italien, Japan, Kanada, USA) und der Europäischen...
► Artikel lesen
04.10.24Motorsport Games Inc.: Motorsport Games Considering Strategic Alternatives226MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Motorsport Games Inc. (NASDAQ: MSGM) ("Motorsport Games" or "the Company") is announcing that the Board of Directors has authorized management to consider...
► Artikel lesen
04.10.24ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)149SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address...
► Artikel lesen
04.10.24Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08441PURCHASE, NY, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to three new employees....
► Artikel lesen
04.10.24Cidara Therapeutics, Inc.: Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)228SAN DIEGO, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies...
► Artikel lesen
04.10.24NewAmsterdam Pharma Company N.V.: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)166NAARDEN, the Netherlands and MIAMI, Oct. 04, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or "NewAmsterdam" or the "Company"), a late-stage, clinical biopharmaceutical company...
► Artikel lesen
04.10.24Urgent.ly Inc.: Urgently Notified By Nasdaq Of Non-Compliance With Nasdaq Minimum Bid Price Requirement186VIENNA, Va., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Urgent.ly Inc. (Nasdaq: ULY) ("Urgently"), a U.S.-based leading provider of digital roadside and mobility assistance technology and services, announced...
► Artikel lesen
04.10.24Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)200BRISBANE, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on October 2, 2024, the Compensation Committee granted inducement awards consisting...
► Artikel lesen
04.10.24Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)235 WALTHAM, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant...
► Artikel lesen
04.10.24Niu Technologies Provides Third Quarter 2024 Sales Volume Update267BEIJING, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Niu Technologies ("NIU", or "the Company") (NASDAQ: NIU), the world's leading provider of smart urban mobility solutions, today provides its sales volume...
► Artikel lesen
04.10.24Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)249LAKE FOREST, Ill., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering...
► Artikel lesen
04.10.24Psyence Biomedical Ltd.: Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant181NEW YORK, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) ("Psyence Biomed" or the "Company"), a developer of psilocybin-based therapeutics, today provided an update on its...
► Artikel lesen
04.10.24Trevena, Inc.: Trevena Announces Receipt of Nasdaq Delisting Notification299CHESTERBROOK, Pa., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
► Artikel lesen
Seite:  Weiter >>